1. Home
  2. Labeler Index
  3. Tower Laboratories Ltd
  4. 50201-0421
  5. NDC Package Code: 50201-0421-2 Bromo Seltzer

NDC Package 50201-0421-2 Bromo Seltzer

Aspirin,Sodium Bicarbonate,Citric Acid Tablet, Effervescent Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
50201-0421-2
Package Description:
10 POUCH in 1 CARTON / 2 TABLET, EFFERVESCENT in 1 POUCH
Product Code:
50201-0421
Proprietary Name:
Bromo Seltzer
Non-Proprietary Name:
Aspirin, Sodium Bicarbonate, Citric Acid
Substance Name:
Anhydrous Citric Acid; Aspirin; Sodium Bicarbonate
Usage Information:
■ do not exceed recommended dosage■ to avoid serious injury, completely dissolve tablets in 4 oz. of water before taking■ adults and children 12 years and over (up to 60 years of age): 2 tablets every 4 hours - do not exceed 8 tablets in 24 hrs■ 60 years and over: 2 tablets every 4 hours - do not exceed 4 tablets in 24 hrs
11-Digit NDC Billing Format:
50201042102
NDC to RxNorm Crosswalk:
  • RxCUI: 1536675 - aspirin 325 MG / citric acid 1000 MG / sodium bicarbonate 1916 MG Effervescent Oral Tablet
  • RxCUI: 1536675 - ASA 325 MG / Citric Acid 1000 MG / NaHCO3 1916 MG Effervescent Oral Tablet
  • RxCUI: 1537012 - BROMO SELTZER Antacid Pain Reliever 325 MG / 1000 MG / 1916 MG Effervescent Oral Tablet
  • RxCUI: 1537012 - aspirin 325 MG / citric acid 1000 MG / sodium bicarbonate 1916 MG Effervescent Oral Tablet [Bromo Seltzer Antacid Pain Reliever]
  • RxCUI: 1537012 - ASA 325 MG / Citric Acid 1000 MG / NaHCO3 1916 MG Effervescent Oral Tablet [Bromo Seltzer Antacid Pain Reliever]
    • Product Type:
    Human Otc Drug
    Labeler Name:
    Tower Laboratories Ltd
    Dosage Form:
    Tablet, Effervescent - A solid dosage form containing mixtures of acids (e.g., citric acid, tartaric acid) and sodium bicarbonate, which release carbon dioxide when dissolved in water; it is intended to be dissolved or dispersed in water before administration.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • ANHYDROUS CITRIC ACID 1000 mg/1
  • ASPIRIN 325 mg/1
  • SODIUM BICARBONATE 1916 mg/1
    • Pharmacologic Class(es):
  • Acidifying Activity - [MoA] (Mechanism of Action)
  • Alkalinizing Activity - [MoA] (Mechanism of Action)
  • Anti-Inflammatory Agents, Non-Steroidal - [CS]
  • Anti-coagulant - [EPC] (Established Pharmacologic Class)
  • Calcium Chelating Activity - [MoA] (Mechanism of Action)
  • Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
  • Cyclooxygenase Inhibitors - [MoA] (Mechanism of Action)
  • Decreased Coagulation Factor Activity - [PE] (Physiologic Effect)
  • Decreased Platelet Aggregation - [PE] (Physiologic Effect)
  • Decreased Prostaglandin Production - [PE] (Physiologic Effect)
  • Nonsteroidal Anti-inflammatory Drug - [EPC] (Established Pharmacologic Class)
  • Platelet Aggregation Inhibitor - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    FDA Application Number:
    part343
    Marketing Category:
    OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
    Start Marketing Date:
    07-16-2012
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 50201-0421-2?

    The NDC Packaged Code 50201-0421-2 is assigned to a package of 10 pouch in 1 carton / 2 tablet, effervescent in 1 pouch of Bromo Seltzer, a human over the counter drug labeled by Tower Laboratories Ltd. The product's dosage form is tablet, effervescent and is administered via oral form.

    Is NDC 50201-0421 included in the NDC Directory?

    Yes, Bromo Seltzer with product code 50201-0421 is active and included in the NDC Directory. The product was first marketed by Tower Laboratories Ltd on July 16, 2012 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 50201-0421-2?

    The 11-digit format is 50201042102. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-150201-0421-25-4-250201-0421-02